CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-13.82%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$6.51B
AUM Growth
-$1.02B
(-13%)
Cap. Flow
+$50.5M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
20.49%
Holding
900
New
86
Increased
331
Reduced
275
Closed
84
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$52.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$29.4M |
| 3 |
Biogen
BIIB
|
+$18.6M |
| 4 |
Mastercard
MA
|
+$17.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$17.5M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
+$50.7M |
| 2 |
Ecopetrol
EC
|
+$21.5M |
| 3 |
AET
Aetna Inc
AET
|
+$20.2M |
| 4 |
Amgen
AMGN
|
+$19.2M |
| 5 |
Merck
MRK
|
+$18.5M |
Sector Composition
| 1 | Healthcare | 35.32% |
| 2 | Technology | 15.37% |
| 3 | Financials | 11.61% |
| 4 | Consumer Discretionary | 8.19% |
| 5 | Communication Services | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Kura Oncology
KURA
$695M
| $5.14M | 0.08% |
366,000
| – | – |
|
277
Dominion Energy
D
$50.2B
| $5.11M | 0.08% |
71,536
+12,877
| +22% | +$920K |
|
|
TFCFA
278
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $5.1M | 0.08% |
106,033
-1,700
| -2% | -$81.8K |
|
279
Ultragenyx Pharmaceutical
RARE
$3.04B
| $5.02M | 0.08% |
115,500
+2,400
| +2% | +$104K |
|
|
RDUS
280
DELISTED
Radius Health, Inc.
RDUS
| $5.01M | 0.08% |
304,025
| – | – |
|
281
Bank of New York Mellon
BK
$73.9B
| $4.95M | 0.08% |
105,221
+21,925
| +26% | +$1.03M |
|
|
IMGN
282
DELISTED
Immunogen Inc
IMGN
| $4.9M | 0.08% |
1,021,139
+68,639
| +7% | +$329K |
|
283
Exelon
EXC
$43.5B
| $4.88M | 0.08% |
151,744
+20,399
| +16% | +$656K |
|
284
Suncor Energy
SU
$49.7B
| $4.87M | 0.07% |
174,573
+27,478
| +19% | +$767K |
|
285
CSX Corp
CSX
$60B
| $4.84M | 0.07% |
233,838
+22,449
| +11% | +$465K |
|
|
APC
286
DELISTED
Anadarko Petroleum
APC
| $4.84M | 0.07% |
110,436
+4,081
| +4% | +$179K |
|
|
DRNA
287
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.78M | 0.07% |
447,500
+156,000
| +54% | +$1.67M |
|
|
RVNC
288
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.77M | 0.07% |
237,000
+66,000
| +39% | +$1.33M |
|
|
MRO
289
DELISTED
Marathon Oil Corporation
MRO
| $4.7M | 0.07% |
327,570
+73,166
| +29% | +$1.05M |
|
290
TC Energy
TRP
$53.9B
| $4.66M | 0.07% |
130,634
+858
| +0.7% | +$30.6K |
|
291
Progressive
PGR
$143B
| $4.66M | 0.07% |
77,212
-116,923
| -60% | -$7.05M |
|
292
Vanda Pharmaceuticals
VNDA
$266M
| $4.65M | 0.07% |
+178,000
| New | +$4.65M |
|
|
GG
293
DELISTED
Goldcorp Inc
GG
| $4.65M | 0.07% |
474,513
+7,079
| +2% | +$69.3K |
|
294
EOG Resources
EOG
$64.1B
| $4.55M | 0.07% |
52,132
-640
| -1% | -$55.8K |
|
|
DNB
295
DELISTED
Dun & Bradstreet
DNB
| $4.54M | 0.07% |
+31,800
| New | +$4.54M |
|
296
Aflac
AFL
$56.8B
| $4.51M | 0.07% |
99,018
-5,530
| -5% | -$252K |
|
297
Supernus Pharmaceuticals
SUPN
$2.58B
| $4.49M | 0.07% |
+135,000
| New | +$4.49M |
|
|
AHL
298
DELISTED
ASPEN Insurance Holding Limited
AHL
| $4.48M | 0.07% |
106,600
| – | – |
|
299
Telus
TU
$25B
| $4.47M | 0.07% |
269,600
+4,802
| +2% | +$79.5K |
|
300
AnaptysBio
ANAB
$619M
| $4.47M | 0.07% |
70,000
| – | – |
|